Effectiveness against Indian B.1.617.2 variant:... - Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

Effectiveness of COVID-19 vaccines Coronavirus · 7.4m followers Shared knowledge and experiences regarding COVID-19 Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared May 23 Effectiveness against Indian B.1.617.2 variant: 1 dose Pfizer 33.2% (8.3-51.4%) N=49 1 dose Oxford 32.9% (19.3-44.3%) N=230... Read More »Loading… Effectiveness of COVID-19 vaccines against the B.1.617.2 variant khub.net 188 upvotes56 comments Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared May 23 Vaccine effectiveness: B.1.1.7: Pfizer 90%, Novavax 86%, AstraZeneca 75% P.1 (Brazil): Johnson & Johnson 66%, Sinovac 50% B.1.351 (South Africa): Pfizer 75%, Johnson & John... Read More »Loading… Bloomberg Bloomberg 62 upvotes12 comments Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared May 25 Early Warning (Being investigated): CDC has received 12+ reports of myocarditis (heart inflammation) appearing within 4 days after vaccination. Seems to happen more often ... Read More »Loading… CDC investigating potential rare side effect from Pfizer, Moderna vaccines KOMO 61 upvotes21 comments Read more in Coronavirus This email was sent by Quora (605 Castro Street, Mountain View, CA 94041). You were sent this email because you are following Coronavirus. If you don't want these updates anymore, you can unfollow Coronavirus or unsubscribehttp://www.quora.com/